General population studies demonstrate that about 30% of the individuals who were taking antidepressants or who were hospitalized for depression had increased levels (i.e., >3 mg/L) of C-reactive protein (CRP), a clinical marker of inflammation [10, 11]. Here, CRP is linked to depressive symptom measurement.